Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A01822 | 34604270 | Front Nutr | Associations of Nutritional, Lifestyle, and Metabolic Factors With Non-alcoholic Fatty Liver Disease: An Umbrella Review With More Than 380,000 Participants. | 2021 | Details |
| A01823 | 34603404 | Front Genet | Corrigendum: Genetic Polymorphism of Vitamin D Family Genes CYP2R1, CYP24A1, and CYP27B1 Are Associated With a High Risk of Non-alcoholic Fatty Liver Disease: A Case-Control Study. | 2021 | Details |
| A01825 | 34603215 | Front Endocrinol (Lausanne) | The Prevalence, Popular Trends, and Associated and Predictive Factors of Non-Obese Fatty Liver Disease. | 2021 | Details |
| A01826 | 34603198 | Front Endocrinol (Lausanne) | Association of ANGPTL8 and Resistin With Diabetic Nephropathy in Type 2 Diabetes Mellitus. | 2021 | Details |
| A01827 | 34603083 | Front Physiol | Drosophila melanogaster: A Powerful Tiny Animal Model for the Study of Metabolic Hepatic Diseases. | 2021 | Details |
| A01828 | 34602548 | Biol Pharm Bull | Accumulation of Toxic Advanced Glycation End-Products Induces Cytotoxicity and Inflammation in Hepatocyte-Like Cells Differentiated from Human Induced Pluripotent Stem Cells. | 2021 | Details |
| A01829 | 34602251 | Gastroenterology | Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01830 | 34602072 | Lipids Health Dis | Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management. | 2021 | Details |
| A01831 | 34601620 | J Gastroenterol | Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan. | 2021 | Details |
| A01832 | 34601385 | Stem Cell Res | In vitro expansion of cirrhosis derived liver epithelial cells with defined small molecules. | 2021 | Details |
| A01833 | 34601002 | Mol Cell Endocrinol | Patchouli alcohol ameliorates skeletal muscle insulin resistance and NAFLD via AMPK/SIRT1-mediated suppression of inflammation. | 2021 | Details |
| A01834 | 34600974 | J Hepatol | TTC39B destabilizes retinoblastoma protein promoting hepatic lipogenesis in a sex-specific fashion. | 2021 | Details |
| A01835 | 34600973 | J Hepatol | ADAMTSL2 protein and a soluble biomarker signature identify at-risk non-alcoholic steatohepatitis and fibrosis in adults with NAFLD. | 2021 | Details |
| A01836 | 34600906 | Metabolism | The presence of NAFLD influences the transition of metabolically healthy to metabolically unhealthy obesity and the ten-year cardiovascular disease risk: A population-based cohort study. | 2021 | Details |
| A01837 | 34599938 | Life Sci | Curcumin activation of nuclear factor E2-related factor 2 gene (Nrf2): Prophylactic and therapeutic effect in nonalcoholic steatohepatitis (NASH). | 2021 | Details |
| A01838 | 34598315 | Immun Inflamm Dis | Multidirectional facets of obesity management in the metabolic syndrome population after liver transplantation. | 2021 | Details |
| A01839 | 34597608 | Life Sci | The role of Sirtuin 2 in sustaining functional integrity of the liver. | 2021 | Details |
| A01840 | 34595203 | Front Nutr | Effects of Oral Vitamin C Supplementation on Liver Health and Associated Parameters in Patients With Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial. | 2021 | Details |
| A01843 | 34593018 | BMC Pharmacol Toxicol | Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis. | 2021 | Details |
| A01844 | 34592488 | Phytomedicine | Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis. | 2021 | Details |
| A01845 | 34592210 | Chemosphere | Blood manganese and nonalcoholic fatty liver disease: A cohort-based case-control study. | 2021 | Details |
| A01846 | 34591986 | Hepatology | OTUB1 alleviates NASH through inhibition of the TRAF6-ASK1 signaling pathways. | 2021 | Details |
| A01847 | 34591699 | J Med Food | Artichoke Extract Directly Suppresses Inflammation and Apoptosis in Hepatocytes During the Development of Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A01848 | 34590877 | J Int Med Res | Relationship between non-alcoholic fatty liver disease and cardiac arrhythmia: a systematic review and meta-analysis. | 2021 | Details |
| A01849 | 34590386 | Pediatr Transplant | Hepatic macrosteatosis in the US pediatric deceased liver donor population. | 2021 | Details |
| A01850 | 34590082 | Aust J Gen Pract | Updates in fatty liver disease: Pathophysiology, diagnosis and management. | 2021 | Details |
| A01851 | 34589520 | Front Mol Biosci | Saliva and Plasma Reflect Metabolism Altered by Diabetes and Periodontitis. | 2021 | Details |
| A01852 | 34588976 | Front Pharmacol | N-Acetyl Cysteine Ameliorates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease and Intracellular Triglyceride Accumulation by Preserving Mitochondrial Function. | 2021 | Details |
| A01853 | 34588764 | Drug Des Devel Ther | Non-Alcoholic Steatohepatitis (NASH) - A Review of a Crowded Clinical Landscape, Driven by a Complex Disease. | 2021 | Details |
| A01854 | 34588551 | Sci Rep | Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis. | 2021 | Details |
| A01855 | 34588540 | Sci Rep | Combination of FIB-4 with ultrasound surface nodularity or elastography as predictors of histologic advanced liver fibrosis in chronic liver disease. | 2021 | Details |
| A01856 | 34587729 | Zhonghua Yi Xue Za Zhi | [Clinical features and risk factors of metabolic syndrome in adult hypopituitary patients]. | 2021 | Details |
| A01857 | 34587704 | Asia Pac J Clin Nutr | Skeletal muscle mass indexes and nonalcoholic fatty liver disease in Chinese elders. | 2021 | Details |
| A01859 | 34586531 | Invest New Drugs | Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practice. | 2021 | Details |
| A01860 | 34585892 | J Assoc Physicians India | Management of Hyperglycemia in COVID-19 and Post-COVID-19 Syndrome - Proposed Guidelines for India. | 2021 | Details |
| A01861 | 34585409 | J Food Biochem | Crataegus aronia prevents high-fat diet-induced hepatic steatosis in rats by activating AMPK-induced suppression of SREBP1 and activation of PPARα. | 2021 | Details |
| A01862 | 34585128 | EClinicalMedicine | The influence of equitable access policies and socioeconomic factors on post-liver transplant survival. | 2021 | Details |
| A01863 | 34584580 | Prz Gastroenterol | Association of non-alcoholic fatty liver disease with coronary artery calcification progression: a systematic review and meta-analysis. | 2021 | Details |
| A01864 | 34583706 | Cardiovasc Diabetol | The association of hepatic steatosis and fibrosis with heart failure and mortality. | 2021 | Details |
| A01865 | 34583137 | Nutrition | Impedance-based measures of muscle mass can be used to predict severity of hepatic steatosis in pediatric nonalcoholic fatty liver disease. | 2021 | Details |
| A01866 | 34580427 | Pediatr Res | Predictors of non-alcoholic fatty liver disease in children. | 2021 | Details |
| A01867 | 34579641 | Endocr Metab Immune Disord Drug Targets | Adiponectin is Inversely Associated with Insulin Resistance in Adolescents with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01868 | 34579068 | Nutrients | The Effect of Probiotics (MCP® BCMC® Strains) on Hepatic Steatosis, Small Intestinal Mucosal Immune Function, and Intestinal Barrier in Patients with Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A01869 | 34579016 | Nutrients | Pancreatic β-Cell Dysfunction Is Associated with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01870 | 34579012 | Nutrients | Positive Effects of Exercise Intervention without Weight Loss and Dietary Changes in NAFLD-Related Clinical Parameters: A Systematic Review and Meta-Analysis. | 2021 | Details |
| A01871 | 34578919 | Nutrients | Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease Incidence, Prevalence and Risk of Significant Liver Fibrosis: Systematic Review with Meta-Analysis of Observational Studies. | 2021 | Details |
| A01872 | 34578867 | Nutrients | Amelioration of Hepatic Steatosis in Mice through Bacteroides uniformis CBA7346-Mediated Regulation of High-Fat Diet-Induced Insulin Resistance and Lipogenesis. | 2021 | Details |
| A01873 | 34578828 | Nutrients | Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD. | 2021 | Details |
| A01874 | 34578806 | Nutrients | Independent Dose-Response Associations between Fetuin-A and Lean Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01875 | 34576229 | Int J Mol Sci | Methyl Brevifolincarboxylate Attenuates Free Fatty Acid-Induced Lipid Metabolism and Inflammation in Hepatocytes through AMPK/NF-κB Signaling Pathway. | 2021 | Details |
| A01876 | 34576136 | Int J Mol Sci | Sex Dimorphism of Nonalcoholic Fatty Liver Disease (NAFLD) in Pparg-Null Mice. | 2021 | Details |
| A01877 | 34576091 | Int J Mol Sci | Establishment of an Adult Medaka Fatty Liver Model by Administration of a Gubra-Amylin-Nonalcoholic Steatohepatitis Diet Containing High Levels of Palmitic Acid and Fructose. | 2021 | Details |
| A01878 | 34576053 | Int J Mol Sci | Anti-Inflammatory Effect of Muscle-Derived Interleukin-6 and Its Involvement in Lipid Metabolism. | 2021 | Details |
| A01879 | 34575934 | Int J Mol Sci | The Anti-Atherosclerotic Action of FFAR4 Agonist TUG-891 in ApoE-Knockout Mice Is Associated with Increased Macrophage Polarization towards M2 Phenotype. | 2021 | Details |
| A01880 | 34575933 | Int J Mol Sci | Perturbation of TM6SF2 Expression Alters Lipid Metabolism in a Human Liver Cell Line. | 2021 | Details |
| A01881 | 34574647 | Int J Environ Res Public Health | Bone Mineral Density in Congenital Generalized Lipodystrophy: The Role of Bone Marrow Tissue, Adipokines, and Insulin Resistance. | 2021 | Details |
| A01882 | 34574082 | Foods | AGL9: A Novel Hepatoprotective Peptide from the Larvae of Edible Insects Alleviates Obesity-Induced Hepatic Inflammation by Regulating AMPK/Nrf2 Signaling. | 2021 | Details |
| A01883 | 34573947 | Diagnostics (Basel) | Determining the Target Population That Would Most Benefit from Screening for Hepatic Fibrosis in a Primary Care Setting. | 2021 | Details |
| A01884 | 34573421 | Genes (Basel) | The Mitochondrial Trigger in an Animal Model of Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01885 | 34572959 | Cancers (Basel) | Senescence in HBV-, HCV- and NAFLD- Mediated Hepatocellular Carcinoma and Senotherapeutics: Current Evidence and Future Perspective. | 2021 | Details |
| A01886 | 34572795 | Cancers (Basel) | Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01887 | 34572442 | Biomedicines | Dietary Patterns Influence Target Gene Expression through Emerging Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01888 | 34572434 | Biomedicines | Clinical Significance of HSPD1/MMP14/ITGB1/miR-6881-5P/Lnc-SPARCL1-1:2 RNA Panel in NAFLD/NASH Diagnosis: Egyptian Pilot Study. | 2021 | Details |
| A01889 | 34572415 | Biomedicines | Cisd2 Preserves the Youthful Pattern of the Liver Proteome during Natural Aging of Mice. | 2021 | Details |
| A01890 | 34572279 | Biomedicines | Associations of Dietary Lipid-Soluble Micronutrients with Hepatic Steatosis among Adults in the United States. | 2021 | Details |
| A01891 | 34572151 | Cells | Beyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology. | 2021 | Details |
| A01892 | 34571924 | Cells | Perspectives on Mitochondria-ER and Mitochondria-Lipid Droplet Contact in Hepatocytes and Hepatic Lipid Metabolism. | 2021 | Details |
| A01893 | 34571189 | J Nutr Biochem | Grape pomace reduces the severity of non-alcoholic hepatic steatosis and the development of steatohepatitis by improving insulin sensitivity and reducing ectopic fat deposition in mice. | 2021 | Details |
| A01894 | 34570916 | Aliment Pharmacol Ther | Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non-alcoholic fatty liver disease assessed by magnetic resonance imaging. | 2021 | Details |
| A01895 | 34570568 | Bratisl Lek Listy | Serum butyrylcholinesterase activities in patients with non-alcoholic fatty liver disease. Comparison with liver proteosynthetic function and liver fibrosis. | 2021 | Details |
| A01896 | 34568346 | Front Cell Dev Biol | Analysis of miRNAs Profiles in Serum of Patients With Steatosis and Steatohepatitis. | 2021 | Details |
| A01897 | 34568090 | Front Cell Infect Microbiol | Disease-Associated Gut Microbiota Reduces the Profile of Secondary Bile Acids in Pediatric Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01898 | 34567490 | J Healthc Eng | Study on Syndrome Intervention of Nonalcoholic Fatty Liver Disease from the Perspective of Deficiency and Excess. | 2021 | Details |
| A01899 | 34567270 | Therap Adv Gastroenterol | Primary care and referring physician perspectives on non-alcoholic fatty liver disease management: a nationwide survey. | 2021 | Details |
| A01900 | 34566696 | Front Physiol | Liver Zonation - Revisiting Old Questions With New Technologies. | 2021 | Details |
| A01901 | 34566670 | Front Physiol | Gardenoside Hinders Caspase-1-Mediated Hepatocyte Pyroptosis Through the CTCF/DPP4 Signaling Pathway. | 2021 | Details |
| A01902 | 34566663 | Front Pharmacol | Preclinical Evidence of Berberine on Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Animal Studies. | 2021 | Details |
| A01903 | 34566646 | Front Pharmacol | Integrating Network Pharmacology and RT-qPCR Analysis to Investigate the Mechanisms Underlying ZeXie Decoction-Mediated Treatment of Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A01904 | 34565785 | Korean J Gastroenterol | Early Cardiac Dysfunction in Biopsy-proven Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A01905 | 34565765 | J Atheroscler Thromb | Circulating PCSK7 Level is Independently Associated with Obesity, Triglycerides Level and Fatty Liver Index in a General Population without Medication. | 2021 | Details |
| A01906 | 34565720 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | Abnormal m6A modification in non-alcoholic fatty liver disease. | 2021 | Details |
| A01907 | 34565410 | Malar J | Transcriptome-based analysis of blood samples reveals elevation of DNA damage response, neutrophil degranulation, cancer and neurodegenerative pathways in Plasmodium falciparum patients. | 2021 | Details |
| A01908 | 34565261 | Int J Food Sci Nutr | The effect of a Mediterranean diet vs. a low-fat diet on non-alcoholic fatty liver disease in children: a randomized trial. | 2021 | Details |
| A01909 | 34565074 | Rev Cardiovasc Med | Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease. | 2021 | Details |
| A01910 | 34564946 | Liver Int | A novel quantitative ultrasound technique for identifying non-alcoholic steatohepatitis. | 2021 | Details |
| A01911 | 34564931 | Liver Transpl | Evaluating Outcomes Related to Donor and Recipient Metabolic Environment: Macrosteatotic Allografts and Nonalcoholic Steatohepatitis. | 2021 | Details |
| A01912 | 34564899 | J Intern Med | Inflammatory and fibrotic mechanisms in NAFLD-Implications for new treatment strategies. | 2021 | Details |
| A01913 | 34564441 | Metabolites | Lipid Profile and Hepatic Fat Content Measured by 1H MR Spectroscopy in Patients before and after Liver Transplantation. | 2021 | Details |
| A01914 | 34564380 | Metabolites | Identification of a Variant in APOB Gene as a Major Cause of Hypobetalipoproteinemia in Lebanese Families. | 2021 | Details |
| A01915 | 34564157 | Mar Drugs | Dieckol Decreases Caloric Intake and Attenuates Nonalcoholic Fatty Liver Disease and Hepatic Lymphatic Vessel Dysfunction in High-Fat-Diet-Fed Mice. | 2021 | Details |
| A01917 | 34563665 | J Nutr Biochem | Cholic acid supplementation accelerates the progression of nonalcoholic fatty liver disease to the procarcinogenic state in mice fed a high-fat and high-cholesterol diet. | 2021 | Details |
| A01918 | 34563519 | J Lipid Res | Inhibition of chylomicron assembly leads to dissociation of hepatic steatosis from inflammation and fibrosis. | 2021 | Details |
| A01919 | 34562443 | J Pediatr | The Prevalence of Elevated Alanine Aminotransferase Levels Meeting Clinical Action Thresholds in Children with Obesity in Primary Care Practice. | 2021 | Details |
| A01920 | 34561962 | J Diabetes Investig | Metabolic associated fatty liver disease is a risk factor for chronic kidney disease. | 2021 | Details |
| A01921 | 34561722 | Eur J Nutr | Effects of β-glucan, probiotics, and synbiotics on obesity-associated colitis and hepatic manifestations in C57BL/6J mice. | 2021 | Details |
| A01922 | 34560854 | Cardiovasc Diabetol | Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study. | 2021 | Details |
| A01923 | 34560694 | Eur J Gastroenterol Hepatol | Healthcare practitioners' diagnostic and treatment practice patterns of nonalcoholic fatty liver disease in Poland: a cross-sectional survey. | 2022 | Details |
| A01924 | 34560608 | Clin Nutr | Dietary patterns and risk of non-alcoholic fatty liver disease in adults: A prospective cohort study. | 2021 | Details |
| A01925 | 34560554 | Biomed Pharmacother | Regulation of decorin by ursolic acid protects against non-alcoholic steatohepatitis. | 2021 | Details |
| A01926 | 34560278 | Clin Gastroenterol Hepatol | A Meta-Analysis on the Global Prevalence, Risk factors and Screening of Coronary Heart Disease in Nonalcoholic Fatty Liver Disease. | 2021 | Details |